Healthy Directions After Lung Surgery Pilot
Study Details
Study Description
Brief Summary
The objective of this proposal is to test the feasibility and acceptability of a lifestyle risk reduction intervention for patients with lung cancer receiving surgical treatment. This study will provide the preliminary data needed to conduct a larger randomized controlled trial that tests an innovative, multidisciplinary intervention that has the potential to transform the standard of care for patients receiving surgical treatment for lung cancer.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Lifestyle counseling This is a single arm, quasi-experimental, pre- and post- test study design to test the feasibility and acceptability of a multiple risk factor, lifestyle intervention in patients receiving surgical treatment for lung cancer or those suspected of having lung cancer. |
Behavioral: Lifestyle counseling
|
Outcome Measures
Primary Outcome Measures
- Feasibility and acceptability [at end of study (4 months post intervention)]
The primary outcome measures to establish feasibility and acceptability of the intervention for this study are enrollment rates.
- Feasibility and acceptability [at end of study (4 months post intervention)]
The primary outcome measures to establish feasibility and acceptability patient's use of intervention materials
- Feasibility and acceptability [at end of study (4 months post intervention]
The primary outcome measures to establish feasibility and acceptability of the completion of self-monitoring
- Feasibility and acceptability [at end of study (4 months post intervention)]
The primary outcome measures to establish feasibility and acceptability of the intervention for this study completion of nurse-patient contacts.
Secondary Outcome Measures
- Interest for this study [baseline, 1 month, & 4 month]
The secondary outcome measures of interest for this study are lifestyle risk reduction and Health Related-Quality of Life.
- Interest for this study [baseline, 1 month, & 4 month]
The secondary outcome measures of interest for this study is an interview to evaluate the intervention will be conducted with the participant and the partner at the conclusion of the study.
Eligibility Criteria
Criteria
Patient Inclusion Criteria:
-
21 years of age
-
English speaking
-
MD approval to participate in study
-
Meets one of the inclusions below:
-
- a histological diagnosis of NSCLC undergoing potentially curative treatment
-
- OR those undergoing surgical procedures for lung cancer (includes patients undergoing diagnostic testing or those presenting with lung nodules
-
3.OR patients who have had a surgical procedure for lung cancer within the last six months.
-
May invite a buddy to join study with them defined as a friend, partner, adult child or sibling
Buddy Inclusion Criteria:
-
≥ 21 years of age,
-
English speaking, who is invited by the subject to join as a support person (e.g., friend, partner, adult child or sibling)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Brigham & Woman's Hospital | Boston | Massachusetts | United States | 02115 |
2 | Dana Farber Cancer Institute | Boston | Massachusetts | United States | 02115 |
Sponsors and Collaborators
- Dana-Farber Cancer Institute
- Brigham and Women's Hospital
- University of Massachusetts, Boston
Investigators
- Principal Investigator: Mary E. Cooley, PhD, RN, FAAN, Dana Farber Cancer Insitute
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 12-150